These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 25758302)

  • 21. New antiepileptic drugs that are second generation to existing antiepileptic drugs.
    Bialer M
    Expert Opin Investig Drugs; 2006 Jun; 15(6):637-47. PubMed ID: 16732716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
    Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M
    Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?
    Goodman CW; Brett AS
    N Engl J Med; 2017 Aug; 377(5):411-414. PubMed ID: 28767350
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin.
    Bockbrader HN; Wesche D; Miller R; Chapel S; Janiczek N; Burger P
    Clin Pharmacokinet; 2010 Oct; 49(10):661-9. PubMed ID: 20818832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine drug testing of chronic pain patients. IV. prevalence of gabapentin and pregabalin.
    Heltsley R; Depriest A; Black DL; Robert T; Caplan YH; Cone EJ
    J Anal Toxicol; 2011 Jul; 35(6):357-9. PubMed ID: 21740692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended-release drug formulations for the treatment of epilepsy.
    Brandt C; May TW
    Expert Opin Pharmacother; 2018 Jun; 19(8):843-850. PubMed ID: 29672177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability.
    Svendsen T; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI; Johannessen Landmark C
    Neurochem Res; 2017 Jul; 42(7):2077-2083. PubMed ID: 28349359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications.
    Baftiu A; Johannessen Landmark C; Rusten IR; Feet SA; Johannessen SI; Larsson PG
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1245-1254. PubMed ID: 27411937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005.
    Savica R; Beghi E; Mazzaglia G; Innocenti F; Brignoli O; Cricelli C; Caputi AP; Musolino R; Spina E; Trifirò G
    Eur J Neurol; 2007 Dec; 14(12):1317-21. PubMed ID: 17903210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions.
    Gilron I
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):456-72. PubMed ID: 17873599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A population pharmacokinetic model of gabapentin developed in nonparametric adaptive grid and nonlinear mixed effects modeling.
    Carlsson KC; van de Schootbrugge M; Eriksen HO; Moberg ER; Karlsson MO; Hoem NO
    Ther Drug Monit; 2009 Feb; 31(1):86-94. PubMed ID: 19077930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study.
    Peltola J; Peltola M; Auvinen A; Raitanen J; Fallah M; Keränen T
    Acta Neurol Scand; 2009 Jan; 119(1):55-60. PubMed ID: 18616622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative pain management--is there a role for gabapentin or pregabalin?
    Golembiewski JA
    J Perianesth Nurs; 2007 Apr; 22(2):136-8. PubMed ID: 17395082
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic variability of valproate in women of childbearing age.
    Johannessen Landmark C; Burns ML; Baftiu A; Farmen AH; Lossius MI; Johannessen SI; Tomson T
    Epilepsia; 2017 Oct; 58(10):e142-e146. PubMed ID: 28833045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence, regulation and 'rational' prescribing: the case of gabapentin for neuropathic pain.
    Ghinea N; Lipworth W; Kerridge I
    J Eval Clin Pract; 2015 Feb; 21(1):28-33. PubMed ID: 24986307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of gabapentin, pregabalin, vigabatrin, and topiramate in plasma by HPLC with fluorescence detection.
    Martinc B; Roškar R; Grabnar I; Vovk T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():82-88. PubMed ID: 24907547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pregabalin and gabapentin in multiple sclerosis: clinical experiences and therapeutic implications].
    Bittner S; Höhn K; Göbel K; Kleinschnitz C; Wiendl H; Meuth SG
    Nervenarzt; 2011 Oct; 82(10):1273-80. PubMed ID: 21647743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
    Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
    Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost analysis of adding pregabalin or gabapentin to the management of community-treated patients with peripheral neuropathic pain.
    Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Planas-Comes A
    J Eval Clin Pract; 2012 Dec; 18(6):1170-9. PubMed ID: 21883712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.